Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 2

1(20.0%)

5Total

N/A(4)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04603625Not ApplicableCompleted

Postural Management for Hip Luxation in Quadriplegic Cerebral Palsy

Role: collaborator

NCT07131995Completed

Formative Usability Testing Study of a Novel Medical Device for Peritoneal Dialysis (WEAKID)

Role: collaborator

NCT02306109Not ApplicableCompleted

Effect of Motor Rehabilitation Treatment on Amyotrophic Lateral Sclerosis (ALS)

Role: lead

NCT03592420Not ApplicableCompleted

PRE.C.I.S.A - Fall Prevention and Promotion of Active and Healthy Aging

Role: lead

NCT03582345Not ApplicableCompleted

Investigation of Human Epileptic Networks by fMRI

Role: lead

NCT01911559Completed

Effectiveness of Standing Frame on Constipation in Children With Cerebral Palsy

Role: collaborator

NCT01477801Phase 2Unknown

Effects of Cholecalciferol Supplementation in Patients With Chronic Heart Failure and LOw vITamind D Levels

Role: lead

All 7 trials loaded